UIPATH INC - CLASS A (PATH) Forecast, Price Target & Analyst Ratings

NYSE:PATH • US90364P1057

Current stock price

11.24 USD
+0.22 (+2%)
At close:
11.24 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for UIPATH INC - CLASS A (PATH).

Forecast Snapshot

Consensus Price Target

Price Target
$14.06
+ 25.09% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 27, 2026
Period
Q1 / 2027
EPS Estimate
$0.16
Revenue Estimate
405.77M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
67.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$14.06
Upside
+ 25.09%
From current price of $11.24 to mean target of $14.06, Based on 28 analyst forecasts
Low
$12.12
Median
$13.72
High
$17.85

Price Target Revisions

1 Month
-14.73%
3 Months
-14.44%

Price Target Summary

28 Wall Street analysts provided a forecast for the next 12 months for PATH. The average price target is 14.06 USD. This implies a price increase of 25.09% is expected in the next year compared to the current price of 11.24.
The average price target has been revised downward by 14.44% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PATH Current Analyst RatingPATH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

PATH Historical Analyst RatingsPATH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
67.86%
PATH was analyzed by 28 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about PATH.
In the previous month the buy percentage consensus was at a similar level.
PATH was analyzed by 28 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-16BMO CapitalMaintains Market Perform -> Market Perform
2026-03-12TD CowenMaintains Hold -> Hold
2026-03-12MizuhoMaintains Neutral -> Neutral
2026-03-12DA DavidsonMaintains Neutral -> Neutral
2026-03-12UBSMaintains Neutral -> Neutral
2026-03-12NeedhamUpgrade Hold -> Buy
2026-03-12Wells FargoMaintains Equal-Weight -> Equal-Weight
2026-03-12Truist SecuritiesMaintains Hold -> Hold
2026-03-12Canaccord GenuityMaintains Buy -> Buy
2026-03-12B of A SecuritiesMaintains Underperform -> Underperform
2026-03-12Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2026-01-12BarclaysMaintains Equal-Weight -> Equal-Weight
2026-01-05RBC CapitalMaintains Sector Perform -> Sector Perform
2025-12-10RBC CapitalMaintains Sector Perform -> Sector Perform
2025-12-09Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-12-05DA DavidsonMaintains Neutral -> Neutral
2025-12-04MizuhoMaintains Neutral -> Neutral
2025-12-04BMO CapitalMaintains Market Perform -> Market Perform
2025-12-04NeedhamReiterate Hold -> Hold
2025-12-04RBC CapitalMaintains Sector Perform -> Sector Perform
2025-12-04BarclaysMaintains Equal-Weight -> Equal-Weight
2025-12-04Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-12-04Evercore ISI GroupMaintains In-Line -> In-Line
2025-12-04Canaccord GenuityMaintains Buy -> Buy
2025-10-23UBSUpgrade Sell -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 27, 2026
Period
Q1 / 2027
EPS Estimate
$0.16
Revenue Estimate
405.77M
Revenue Q2Q
13.78%
EPS Q2Q
48.00%
Number of Analysts
22

Next Earnings Revisions

Revenue (1 Month)
0.96%
Revenue (3 Months)
1.26%
EPS (1 Month)
2.66%
EPS (3 Months)
4.60%

Next Earnings Summary

PATH is expected to report earnings on 5/27/2026. The consensus EPS estimate for the next earnings is 0.16 USD and the consensus revenue estimate is 405.77M USD.
The next earnings revenue estimate has been revised upward by 1.26% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2027 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
PATH revenue by date.PATH revenue by date.
1.308B
23.57%		1.43B
9.30%		1.611B
12.65%		1.801B
11.82%		1.954B
8.50%		2.107B
7.83%		2.528B
19.98%		2.68B
6.01%
EBITDA
YoY % growth
PATH ebitda by date.PATH ebitda by date.
-139.497M
54.44%		-120.611M
13.54%		78.136M
164.78%		430.03M
450.36%		484.08M
12.57%		495.72M
2.40%		582.42M
17.49%		671.16M
15.24%
EBIT
YoY % growth
PATH ebit by date.PATH ebit by date.
-162.094M
50.11%		-137.843M
14.96%		61.167M
144.37%		421.84M
589.65%		480.89M
14.00%		544.3M
13.19%		564.06M
3.63%		652.8M
15.73%
Operating Margin
PATH operating margin by date.PATH operating margin by date.
-12.39%-9.64%3.80%23.42%24.61%25.83%22.31%24.36%
EPS
YoY % growth
PATH eps by date.PATH eps by date.
0.54
260.00%		0.54
0.00%		0.72
33.33%		0.78
8.02%		0.84
7.92%		0.52
-38.02%		0.59
13.73%		0.66
12.07%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28 Q1 / 29 Q2 / 29 Q3 / 29 Q4 / 29
EPS
Q2Q % growth		0.16
48.00%		0.15
2.30%		0.19
19.71%		0.31
2.89%		0.18
11.81%		0.17
13.06%		0.22
12.73%		0.35
12.61%		0.23
28.88%		0.21
23.47%		0.28
27.54%		0.42
20.32%
Revenue
Q2Q % growth		405.77M
13.78%		404.63M
11.86%		450.97M
9.69%		530.47M
10.26%		436.35M
7.54%		441.37M
9.08%		487.44M
8.09%		571.64M
7.76%		470.18M
7.75%		473.95M
7.38%		520.9M
6.86%		613.91M
7.39%
EBITDA
Q2Q % growth		87.724M
964.45%		81.681M
822.46%		107.4M
328.45%		174.6M
79.53%		102.11M
16.40%		95.885M
17.39%		130.66M
21.66%		198.22M
13.53%		145.28M
42.28%		133.95M
39.70%		176.51M
35.09%		272.12M
37.28%
EBIT
Q2Q % growth		81.506M
708.21%		76.122M
505.14%		99.203M
658.95%		166.47M
107.35%		91.545M
12.32%		88.634M
16.44%		116.71M
17.65%		191.74M
15.18%		119.24M
30.25%		107.05M
20.78%		144.17M
23.53%		225.98M
17.86%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PATH Yearly Revenue VS EstimatesPATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
PATH Yearly EPS VS EstimatesPATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6 0.8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-10.27%
EPS Next 5 Year
-1.64%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
9.04%
Revenue Next 5 Year
10.52%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
10.77%
EBIT Next 5 Year
12.97%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

UIPATH INC - CLASS A / PATH Forecast FAQ

What is the price target for PATH stock?

28 analysts have analysed PATH and the average price target is 14.06 USD. This implies a price increase of 25.09% is expected in the next year compared to the current price of 11.24.

What is the next earnings date for PATH stock?

UIPATH INC - CLASS A (PATH) will report earnings on 2026-05-27, after the market close.

Can you provide the consensus estimates for UIPATH INC - CLASS A next earnings?

The consensus EPS estimate for the next earnings of UIPATH INC - CLASS A (PATH) is 0.16 USD and the consensus revenue estimate is 405.77M USD.

What is the consensus rating for UIPATH INC - CLASS A (PATH) stock?

The consensus rating for UIPATH INC - CLASS A (PATH) is 67.8571 / 100 . This indicates that analysts generally have a neutral outlook on the stock.